- Home
- ASM vs STAA Comparison
ASM vs STAA Comparison
Compare ASM & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASM | STAA |
|---|---|---|
| Founded | 1968 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Ophthalmic Goods |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2005 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ASM | STAA |
|---|---|---|
| Price | $6.45 | $22.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $8.18 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 4.4M | 874.6K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $53.35 | $30.82 |
| Revenue Next Year | $34.26 | $8.41 |
| P/E Ratio | ★ $67.93 | $90.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.05 | $15.59 |
| 52 Week High | $11.99 | $35.87 |
Technical Indicators
Market Signals| Indicator | ASM | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 47.81 |
| Support Level | $6.84 | $23.27 |
| Resistance Level | $7.47 | $24.26 |
| Average True Range (ATR) | 0.36 | 0.82 |
| MACD | -0.07 | 0.17 |
| Stochastic Oscillator | 22.45 | 70.13 |
Price Performance
Historical ComparisonAbout ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.